Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice

Abstract In humans, loss-of-function mutations in the UBE3A gene lead to the neurodevelopmental disorder Angelman syndrome (AS). AS patients have severe impairments in speech, learning and memory, and motor coordination, for which there is currently no treatment. In addition, UBE3A is duplicated in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gabrielle L. Sell, Wendy Xin, Emily K. Cook, Mark A. Zbinden, Thomas B. Schaffer, Robert N. O’Meally, Robert N. Cole, Seth S. Margolis
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/65582c1636854f608ecc07c0e17a093b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:65582c1636854f608ecc07c0e17a093b
record_format dspace
spelling oai:doaj.org-article:65582c1636854f608ecc07c0e17a093b2021-12-02T18:51:14ZDeleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice10.1038/s41598-021-97898-w2045-2322https://doaj.org/article/65582c1636854f608ecc07c0e17a093b2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97898-whttps://doaj.org/toc/2045-2322Abstract In humans, loss-of-function mutations in the UBE3A gene lead to the neurodevelopmental disorder Angelman syndrome (AS). AS patients have severe impairments in speech, learning and memory, and motor coordination, for which there is currently no treatment. In addition, UBE3A is duplicated in > 1–2% of patients with autism spectrum disorders—a further indication of the significant role it plays in brain development. Altered expression of UBE3A, an E3 ubiquitin ligase, is hypothesized to lead to impaired levels of its target proteins, but identifying the contribution of individual UBE3A targets to UBE3A-dependent deficits remains of critical importance. Ephexin5 is a putative UBE3A substrate that has restricted expression early in development, regulates synapse formation during hippocampal development, and is abnormally elevated in AS mice, modeled by maternally-derived Ube3a gene deletion. Here, we report that Ephexin5 can be directly ubiquitylated by UBE3A. Furthermore, removing Ephexin5 from AS mice specifically rescued hippocampus-dependent behaviors, CA1 physiology, and deficits in dendritic spine number. Our findings identify Ephexin5 as a key driver of hippocampal dysfunction and related behavioral deficits in AS mouse models. These results demonstrate the exciting potential of targeting Ephexin5, and possibly other UBE3A substrates, to improve symptoms of AS and other UBE3A-related developmental disorders.Gabrielle L. SellWendy XinEmily K. CookMark A. ZbindenThomas B. SchafferRobert N. O’MeallyRobert N. ColeSeth S. MargolisNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gabrielle L. Sell
Wendy Xin
Emily K. Cook
Mark A. Zbinden
Thomas B. Schaffer
Robert N. O’Meally
Robert N. Cole
Seth S. Margolis
Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
description Abstract In humans, loss-of-function mutations in the UBE3A gene lead to the neurodevelopmental disorder Angelman syndrome (AS). AS patients have severe impairments in speech, learning and memory, and motor coordination, for which there is currently no treatment. In addition, UBE3A is duplicated in > 1–2% of patients with autism spectrum disorders—a further indication of the significant role it plays in brain development. Altered expression of UBE3A, an E3 ubiquitin ligase, is hypothesized to lead to impaired levels of its target proteins, but identifying the contribution of individual UBE3A targets to UBE3A-dependent deficits remains of critical importance. Ephexin5 is a putative UBE3A substrate that has restricted expression early in development, regulates synapse formation during hippocampal development, and is abnormally elevated in AS mice, modeled by maternally-derived Ube3a gene deletion. Here, we report that Ephexin5 can be directly ubiquitylated by UBE3A. Furthermore, removing Ephexin5 from AS mice specifically rescued hippocampus-dependent behaviors, CA1 physiology, and deficits in dendritic spine number. Our findings identify Ephexin5 as a key driver of hippocampal dysfunction and related behavioral deficits in AS mouse models. These results demonstrate the exciting potential of targeting Ephexin5, and possibly other UBE3A substrates, to improve symptoms of AS and other UBE3A-related developmental disorders.
format article
author Gabrielle L. Sell
Wendy Xin
Emily K. Cook
Mark A. Zbinden
Thomas B. Schaffer
Robert N. O’Meally
Robert N. Cole
Seth S. Margolis
author_facet Gabrielle L. Sell
Wendy Xin
Emily K. Cook
Mark A. Zbinden
Thomas B. Schaffer
Robert N. O’Meally
Robert N. Cole
Seth S. Margolis
author_sort Gabrielle L. Sell
title Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
title_short Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
title_full Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
title_fullStr Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
title_full_unstemmed Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
title_sort deleting a ube3a substrate rescues impaired hippocampal physiology and learning in angelman syndrome mice
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/65582c1636854f608ecc07c0e17a093b
work_keys_str_mv AT gabriellelsell deletingaube3asubstraterescuesimpairedhippocampalphysiologyandlearninginangelmansyndromemice
AT wendyxin deletingaube3asubstraterescuesimpairedhippocampalphysiologyandlearninginangelmansyndromemice
AT emilykcook deletingaube3asubstraterescuesimpairedhippocampalphysiologyandlearninginangelmansyndromemice
AT markazbinden deletingaube3asubstraterescuesimpairedhippocampalphysiologyandlearninginangelmansyndromemice
AT thomasbschaffer deletingaube3asubstraterescuesimpairedhippocampalphysiologyandlearninginangelmansyndromemice
AT robertnomeally deletingaube3asubstraterescuesimpairedhippocampalphysiologyandlearninginangelmansyndromemice
AT robertncole deletingaube3asubstraterescuesimpairedhippocampalphysiologyandlearninginangelmansyndromemice
AT sethsmargolis deletingaube3asubstraterescuesimpairedhippocampalphysiologyandlearninginangelmansyndromemice
_version_ 1718377450408247296